Skip to main content
Premium Trial:

Request an Annual Quote

Oncormed Granted US Patent for BRCA1 Gene Coding Sequence

Premium

GAITHERSBURG, Md.--Oncormed here has received a US patent on a full-length coding sequence of the BRCA1 gene that encodes the entire BRCA1 protein. The company's rights in the patented sequence include therapeutics and diagnostic products and services. The company also recently received a worldwide exclusive license to the BRCA2 gene for diagnostic purposes.

"Our objective with respect to this intellectual property is to license BRCA1 for therapeutic use and to broadly license both BRCA1 and BRCA2 for diagnostic development and commercialization," noted Timothy Triche, Oncormed's chairman and CEO. Oncormed develops and provides gene-based diagnostic and information services.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.